Lokatial
Helix TherapeuticsActive session
Medical Affairs

Good morning, Dr. Spence

4 KOL touchpoints this week, 2 advisory boards in planning, 18 new HCP questions, 1 new pivotal readout.

A day with Alexis · pick a scenario
1 of 5
Emsah
Emsah
Lokatial agent
thinking…
Find me the top digital opinion leaders in non-small cell lung cancer across Germany, Austria, and Switzerland.
Reasoning · live
Querying PubMed for NSCLC authors in DACH (24 mo)
What HCPs are asking this month

Real questions from verified HCPs on Relay, aggregated and anonymized. This is what your field actually needs to know.

12 mo
73 oncologists asked about Helix Drug X dosing in renal impairment - knowledge gap identified
Rising interest: combination therapy sequencing (+40% vs last month)
12 questions about pediatric use - outside current label, flagged for medical review
Trending competitor mention: Aurelix-Onco in 18 conversations
Biomarker testing access in community oncology - recurring theme across 31 conversations
KOL · DOL engagement pipeline
4 active
Prof. Klaus Weber
Scientific advisory · MRD · Jul 11, 2026
Pre-cleared
Dr. Elena Conti
Publication collab · ctDNA · Aug 02, 2026
In planning
Prof. Andreas Müller
Adv. board · Neoadjuvant IO · Sep 18, 2026
Scheduled
Dr. Sophie Bauer
Scientific consult · PRO · Jun 28, 2026
Pre-cleared